[Treatment of rapidly progressive glomerulonephritis].
Hirayama
Koichi
K
Kobayashi
Masaki
M
Yamagata
Kunihiro
K
Koyama
Akio
A
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001379:Azathioprine / Q000008:administration & dosage; D001781:Blood Component Removal; D003520:Cyclophosphamide / Q000008:administration & dosage; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000145:classification / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D010951:Plasma Exchange; D020551:Pulse Therapy, Drug
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D009173:Mycophenolic Acid; D001379:Azathioprine; D008775:Methylprednisolone; D008727:Methotrexate